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Dox: Synthetic Hypnotics in the Barbituric Acid Series

SYNTHETIC HYPNOTICS IN THE BARBITURIC
ACID SERIES
ARTHUR W. DOX

The increasing demand for sleep-producing drugs is perhaps one
of the characteristics of the restless age in which we now live. Not
a year passes but half a dozen new synthetic hypnotics appear in
the patent literature and a few of these find their way into the
drug market. Most of these fail to meet the claims made by the
manufacturers and are soon discarded, and the physicians continue
to prescribe the eight or ten more or less familiar drugs that have
survived several decades of clinical experience. Meanwhile, the
chemical and pharmaceutical laboratories continue their search
for the ideal hypnotic, for it must be admitted that none of the
hypnotics in present clay use are entirely free from certain objectionable qualities.
Long before our era of chemical and pharmaceutical research
the sleep-producing properties of opium and alcohol were widely
known. In oriental countries hashish, or Cannabis indica, has been
used for centuries, but this has never become popular in our western civilization. Among the natural drugs, hyocyamus is perhaps
the only other hypnotic of any importance. The first three, opium,
alcohol and cannabis, are decidedly habit-forming. As a matter
of fact, only a very small percentage of the total consumption of
these drugs can be considered legitimate in the sense of being
used under circumstances where a physician would feel justified
in prescribing them.
Opium, including its chief constituent, morphine and the morphine derivatives codeine, heroine, etc., has been both a blessing
and a curse to humanity. For the relief of acute pain, especially
in post-operative surgery, no satisfactory substitute has yet been
discovered. On the other hand, the morphine habit has fastened
itself upon thousands of otherwise useful citizens and left them
physical and moral wrecks. The discovery of synthetic hypnotics
which are now used in a great many cases where morphine was
formerly prescribed represents, therefore, a distinct advance in
medical science. It may be said in general that for the relief of
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insomnia or sleeplessness due to other causes than acute pain, the
use of morphine or its derivatives is no longer necessary.
Curiously enough, none of the synthetic hypnotics bear the
slightest chemical resemblance to morphine. The exact structure
of the morphine molecule is still unknown, but we know that it
is far more complex than any synthetic hypnotic thus far used.
The presence of a phenanthrene nucleus, an oxygen bridge forming a furane ring, two hydroxyls one of which is phenolic and th<::
other alcoholic, ancl a nitrogen ring bearing a methyl group, is
about all that has been definitely proved of the morphine structure. On the other ha1id, some of our common sleep-producing
drugs are extremely simple and easily synthesized. The difference
is not so much in the size as in the compactness of the molecule.
For example, morphine has a molecular weight of 285, and luminal, one of the most poweriul of our ~ynthetic hypnotics, a molecular weight of 232; yet morphine contains five cyclic nuclei ancl
luminal only two.
The great advantage of the synthetic hypnotics over morphi'ne
is in their lack of injurious effect upon the higber brain centers
and in the fact that they are not habit-forming in the ordinary
sense. Individuals are occasionally met with who rely to an
unnecessary extent upon these drugs, but the habit, if it can be
called such, is hardly a physiological craving. For that matter,
any drug may be considered habit-forming. Self-medication is
one of our favorite pastimes. \Ve have only to call to mind the
number of people among our own acquaintance who resort to a
dose of aspirin upon every possible pretext. \Vith the exception
perhaps of chloral hydrate the ordinary sleep-producing drugs
only rarely develop an injurious habit. The reason probably is
their lack of eff~ct upon the higher brain centers and their failure
to produce sensations of exhilaration or mental exaltation.
In briefly reviewing the history of synthetic hypnotics, we find
that chloral hydrate, CC/a CH(OH)2, was the first to be introduced into medicine. Like many others, this substance was known
to chemists years before its medicinal properties were discovered.
Liebig prepared and described chloral hydrate in 1832 but it was
not until 1869 that Liebreich found it to be a hypnotic and in
1874 it was introduced into the British Pharmacopoeia. The
search for other hypnotics then began. Only those which may be
regarded as distinct types and \vhich have come into extensive
use will be alluded to in this brief discussion. Paraldehycle ( CH 3
CJT0) 3 made its appearance in 1883; urethane (C 2 H 5 0CONH 2 ),
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1885 ; hypnone ( C 6 H/.,,~O CH 3 ), in 1886; amylene hydrate
((CH 3 ) 2 C2 H 0 COH), in 1887; sulfonal ((CH 3 ) 2 C(S0
C 2 II 0 ) 2 ) ,
2
in 1888; chloretone (CC/ 3 (CH 3 ) 2 COH), in 1899; and veronal
((C 2 H;J 2 C(CONH) 2 CO), in 1903.
Analogs and homologs of these in which, for example, bromine is substituted for chlorine, or ethyl for methyl, and condensation products with other substances, have made their appearance in great numbers. l\Iany are patented and sold under fantastic names. In practically all cases their therapeutic action is
clue to a chemical structure represented. by one or more of the
substances listed above.
As already stated, the ideal hypnotic has not yet been found.
Chloral hydrate is regarded by many physicians as habit-forming,
and it has a decidedly depressant action on the heart. Urethane,
hypnone and paraldehyde are effective only in comparatively large
doses and have a disagreeable nauseating taste. Paraldehyde is
widely used in hospitals, but is so unpleasant to take that few
physicians would risk losing their practice by administering it to
private patients. Sulfonal, as well as its homolog, trional, has
a tendency to destroy the blood corpuscles. Chloretone and veronal are perhaps the most satisfactory, yet in <loses sufficient to
produce quick results their action is too prolonged. The ideal hypnotic should have a high "factor of safety," that is, a wide range
between effective close and toxic close, and thus minimize the
clanger of over dosage. It should be prompt in its action and
free from after effects. It should not interfere with circulation
or respiration. And lastly, it should be non-habit forming and
at the same time free from disagreeable taste or odor.
Now what is the mode of action of these drugs? Many theories have been proposed but not one of them is entirely satisfactory. As has been stated, they are unlike morphine in that they
do not affect the higher brain centers, their action being probably
limited to the central nervous system and the medulla. The most
ingenious explanation is known as the Overton-Meyer theory of
narcosis. According to this theory the action of synthetic hypnotics is mechanical rather than chemical. Overton found that the
effectiveness of these drugs is proportional to their "distribution
coefficient," that is, the ratio of their solubility in fats and lipoids
to their soTubility in water. Nerve tissue is composed largely of
fats and lipoids, hence there would tend to be an accumulation in
the nerve tissue of such drugs as are more soluble in lipoids than
in water. The nervous system thus becomes partly saturated with
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a foreign substance and its functioning is mechanically retarded.
In support of this theory we have the fact that animals in an
emaciated condition, in other words, with less adipose tissue to
absorb the drug, are more susceptible to hypnotics, also the fact
that certain hypnotics, for example veronal, undergo practically
no change in the body and are finally excreted unchanged. On the
other hand, many substances in the aromatic series for which
hypnotic properties might be predicted from their distribution
coefficients, have no such action. Possibly, as Traube suggests,
surface tension may also be an important factor. Fuchs has
pointed out that all of the hypnotics with the exception of the
sulfones contain a hydroxyl group, or a carbonyl group capable
of tautomerizing to a hydroxyl. The sulfones are the most readily
destroyed in the body and their apparent exception may be ruled
out on the assumption that a transition product containing a hydroxyl is formed from them. It must be admitted, nevertheless,
that the action of hypnotic drugs is still as much a mystery as the
phenomenon of natural sleep.
A discussion of the various types of hypnotics and their chief
representatives would be far beyond the scope of this paper. \Ve
shall limit ourselves therefore to the newest type, the veronal
series, in which the writer has been conducting investigations during the past three years.
Veronal, also known as Barbital, was introduced into medicine
by Fischer and Mering in 1903. It is 5, 5-diethylbarbituric acid,
(C 2 H 5 ) 2 C(CONH)
CO. This substance, like chloral hydrate,
2
was known to chemists long before its physiological action was
discovered. It was first prepared by Conrad and Guthzeit in 1882
by the action of ethyl iodide on the silver salt of barbituric acid.
For twenty years no further attention was paid to it. Then came
the announcement by Fischer and Mering of the remarkable sleepproducing properties of this substance, and a description by Fischer and Dilthey of a far more satisfactory and economical method
of preparing it. Various processes for the manufacture of veronal have been patented, but the method originally described by
Fischer and Dilthey-the condensation of ethyl diethylmalonate
with urea in the presence of sodium ethylate- is the only one that
has been successful on a commercial scale.
Like all of Emil Fischer's work this investigation ·was painstaking and thorough. He prepared a number of homologs of
veronal, among which may be mentioned dimethyl, methyJethyJ,
methylpropyl, dipropyl, ethylpropyl, diisobutyl, diisoamyl and di0
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benzyl-barbitnric acids. \Vith increasing size of these alkyl groups
the hypnotic effect increases up to a certain point, then decreases.
As might be expected, the two extremes, dimethyl and cliisoarnyl,
have very little action, and the intermediate derivatives follow a
parabolic curve with cliprupyl at the peak. Diethylbarbituric acid
with further substitution of the nitrogen, as for example, S,.5-diethyl-1-methylbarbitmic '.Vi,; was found to he toxic. Rephcerncnt
Qf the oxygen in the 2-puition by sulphur, as in 5,S-diethyl-2thiobarbituric acid gave a toxic product, whereas a similar replacement by the irnino group, NH, as in diethylmalonylguanidine,
gave an inert substance. All of these pr.oclucts, it will be noted,
carry two alkyl groups on the 5-carbon atom of the pyrimidine
nucleus. If only one alkyl is present as in monoethyl or monopropyl-barbituric acid hypnotic action is absent. This is also the
case when the barbituric acid ring is opened up, as for example,
the ureide of <liethylmalonic acid.
The dialkylbarbituric acids \Yhich had been almost entirely neglected during the twenty years preceding Fischer's· patent now
became the subject of feverish research activity particularly in the
German laboratories. Patent after patent appeared in rapid succession, mainly of processes for the manufacture of veronal. Most
of these processes are roundabout methods of synthesis and could
not possibly compete with Fischer's method on a commercial scale.
Among the other clialkylbarbituric acids of therapeutic value
for which specific patents have been granted m;cy be mentioned
phenylethyl, cyclohexylethyl, diallyl, phenylallyl, clibutyl and isopropylethyl-harbitnric acids. Phenylethylbarbituric acid, sold
under the names "luminal" and "phenobarbital" is by far the most
important of these. It is said to be two and one-half times as powerful as veronal, and is used extensively in the treatment of epilepsy. \Vhereas the hypnotic effect of veronal is sometimes preceded
by a brief period of excitement, luminal manifests its sedative action almost immediately, and for that reason is often used in the
treatment of violent cases of insanity and to ward off epileptic seizures. Of the other derivatives just mentioned, the diallyl is about
the only one vvhich can be obtained in the market. It is sold under
the name "dial." It is undoubtedly a good hypnotic, but the
Council of Pharmacy and Chemistry of the 1\merican l\Iedical
Association has refused to accept it for "New and Non-Official
Remedies" because of an overstatement of the manufacturer's
claims. The most recent derivative is perhaps isopropylallylbarbituric acid, known as "allonal." At the present writing, one of
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our large pharmaceutical houses is about to put isoamylethylbarbituric acid on the market. A discussion of these new derivative~
is out of the question because very few data are available except
the advertising propaganda. As regards cost of manufacture,
none of these derivatives can compete with veronal, especially
those containing two different alkyl groups. Superior merits or
special uses must be demonstrated if the product is to be a commercial success. This was actually clone in the case of luminal, which
however, is not a competitor of veronal, but a distinct drug used
for special purposes. Butylethylbarbituric acid is on the European
market made under the name "someryl." It was prepared and
described by the writer several \veeks before Carnot and Tiffeneau
published their description of it. Since the cost of manufacture
by any conceivable process would be greater than that of veronal
and its action is not essentially different, we did not consider it
worth while to apply for a patent.
The study of many other drugs has shown that the physiological
action is often clue to some particular grouping of atoms in the
molecule. A classic example is the synthesis of the local anesthetic
procaine based upon a study of the chemical structure of the alkaloid cocaine. Here it was found that the essential groupings
are the benzoyl radical and a tertiary amine. A much simpler derivative containing these two groupings was then prepared and
found to be an excellent substitute for cocaine without the habit
forming tendencies. Similarly, the ideal hypnotic may eventually
be synthesized when we understand fully the structure of the morphine molecule. For the present. however, we are interested in
determining the essential grouping to which veronal owes its hypnotic action. First of all, what grouping has it in common with
other known hypnotics? Phenylethyl-hydantoin, diethylbromacetylurea, diethylhomophthalimide and phenylethyldiketotetrahydrooxazole have, in common with veronal, the grouping CR2-CO-.l'·v' HCO-. It is not unlikely that this grouping is a "hypnophore," to
coin a word analogous to the familiar "chromophore" of the dye
chemist. The alkyl groups ( R,) may of course be varied within
a limited range.
One of the alkyls may be a cyclic structure, e. g. phenyl or
cyclohexyl, but thns far the other alkyl has invariably been an
open chain. Now how would the physiological properties of these
dialkylbarbituric acids be affected if the two alkyls were linked
together into a cyclic structure? The molecule would then consist of hvo cyclic nuclei with a single carbon atom common to
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both; in other words, a spiro deri1.:afrvc, a type of compounds of
which comparatively few representatives are known. The writer,
in collaboration with Lester Yoder, succeeded in preparing several
such compounds. The spiro derivative trimethylenebarbituric acid
corresponds to methylethylbarbituric acid in which the methyl and
ethyl groups are closed into a four-membered ring. Similarly,
pentamethylenebarbituric acid corresponds to ethylpropylbarbituric acid with the terminal carbons of the ethyl and propyl groups
united into a six-membered ring. To our amazement, both of
these derivatives were entirely devoid of hypnotic action. Likewise, the alkylidene-barbituric acids, with a single alkyl group
linked to the 5-carbon of the pyrimidine ring through a double
bond, as benzylidene-barbituric acid, CH,CH=C(CONH),CO,
are inactive.
\Ve then undertook to vary the urea grouping of the barbituric
acid derivatives. By condensing dialkylmalonic esters with amidines instead of urea we obtained a very interesting series of pyrimidines in which the -NH-CO-KH- grouping of the veronal
series was replaced by -KH-CR = N-. These were devoid of
hypnotic action. Evidently then the "hypnophore" group referred
to above is actually the essential part of the molecule. Even so
slight an alteration of the urea grouping as the reduction of the
carbonyl to a methylene had been found by Einhorn to destroy the
hypnotic properties of veronal.
Another series of dialkylbarbituric acids which we prepared
represents the veronal series with a benzyl group in place of one
of the ethyls. Since the comparatively recent introduction of
benzyl derivatives into medicine as antispasmodics, it occurred to
us that the substitution of a benzyl for an ethyl in veronal might
give us a derivative with both hypnotic and antispasmodic properties. Benzylethylbarbituric acid and a number of its homologs
were accordingly prepared. The most active member of the series was the benzylethyl derivative itself. As we anticipated, it
was a powerful hypnotic, but contrary to our expectations, instead of being an antispasmodic it was quite the reverse. The
narcosis produced in the experimental animals was preceded by
tetanic convulsions. Since the publication of this work our results
have been confirmed by Shonle and Moment of Indianapolis.
These startling results led us to a more critical examination of
Macht's deductions regarding benzyl therapy. We are now convinced that the supposed "specific benzyl effect" claimed by Macht
is simply a higher alcohol effect. \Vith the benzyl attached diPublished by UNI ScholarWorks, 1923
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rectly to carbon as in our derivative a hydrolysis into benzyl alcohol is extremely unlikely, whereas in benzyl benzoate and other
benzyl esters such hydrolysis readily occurs. On the basis of
chemical structure our derivative, with the benzyl attached directly to the carbon of a cyclic nucleus, resembles the alkaloid papaverine, on which Macht based his deductions, more closely than
do his benzyl esters. At present we see no possibility of utilizing
benzy lethy lbarbi turic acid therapeutically.
Of the various preparations on the market containing dialkylbarbituric acids only those representing salts with bases can be
considered chemical compounds. The sodium salt of veronal, for
example, appears under the name "medinal." It has the advantage
of greater solubility and for that reason can be used hypodermically, but its action is no different from that of veronal. Salts with
alkaloids can also be procured, and in these preparations the veronal and the alkaloid exert their specific actions independently.
Other preparations, despite the manufacturer's claims to the contrary, are mere mixtures and not chemical combinations. We
considered it of interest therefore to determine the effect of combining a dialkylbarbituric acid in a stable union with other substances of known physiological activity. The products represent
ethylpropyl- and isoamylpropyl-barbituric acids united through the
gamma carbon of the propyl group to diethylamine, ethylaniline,
acetanilide and phenacetin, respectively. Acetanilide and phenacetin, for example, are antipyretics and ethylpropylbarbituric acid
a strong hypnotic. Preliminary tests showed that mixtures in
molecular proportions retained at least 'the hypnotic action of the
barbituric acid. It remained to be determined what the effect
would be of uniting the two constituents in a stable union. The
synthesis of a typical preparation involved the following steps:Ethyl malonate, ethyl ethylmalonate, ethyl ethylbromopropyl-malonate, ethyl ethylacetphenetidinopropyl-malonate, ethylacetphenetidino-propylbarbituric acid. The final product may be represented
by the formula, C 2 Hr.O.CcH 4 N (COCH 3 )CH 2 CH 2 CH 2(C2 H 5 ) C(CONH)2CO. The substance proved to be so stable that even
the acetyl group was very difficult to remove by boiling with strong
acid or alkali. Animal tests showed that the hypnotic properties
0f the barbituric acid had disappeared entirely. This we attribute
to the insolubility of the substance which prevents absorption and
to its great stability which interferes with the liberation of a simple
dialkylbarbituric acid by hydrolysis. On the other hand, the corresponding derivative with diethylamine in place of phenacetin
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was soluble in water but less soluble in organic solvents, thus reversing the distribution coefficient required by the Overton-Meyer
theory. \Ve believe that in these derivatives a molecular magnitude has been reached considerably beyond that encountered in
the ordinary synthetic hypnotics or in morphine itself, without,
however, acquiring the compactness of the alkaloid molecule.
It will be noted from the foregoing discussion that luminal
(phenyletl~ylbarbituric acid) is the only simple disubstituted barbituric acid containing an aromatic radical linked directly to the
pyrimidine nucleus. \Ve found that ethylphenoxybarbituric acid,
vYhich is luminal with an oxygen inserted between the phenyl
group and the pyrimidine ring, was not a hypnotic. Evidently
the phenyl must be attached directly to carbon. The question
now arises whether the introduction of a second phenyl would
increase the physiological activity stilI further. A search through
the literature showed that no attempts have been recorded to prepare such derivatives. The simplest of this type would be 5.5-diphenyl-barbituric acid, i. e., veronal with both ethyls replaced by
phenyls. An isomer of this has been described, viz., 1, 3-diphenylbarbituric acid, but here both of the phenyls are attached to nitrogen instead of carbon and the substance therefore does not belong to the veronal series. Our attempts to prepare 5, 5-diphenylbarbituric acid were unsuccessful owing to the instability of ethyl
diphenylmalonate which was used in the final step of the synthesis.
\Ve did however, prepare a substituted derivative, namely, di(p-hydroxyphenyl )-barbituric acid, (HOC6 H 4 ) 2 C( CONH) 2 CO,
also its isomer diphenoxybarbituric acid, ( CH,Q) ,c (CON I!) ,co.
Neither of these substances showed physiological activity.
An examination of the structure of the synthetic hypnotics
commonly used shows that practicaliy all are aliphatic derivatives.
\Vhere an aromatic grouping is present, as in luminal and phenylethylhydantoin, the aromatic group comprises a relatively small
part of the molecule. On the other hand, aromatic deriYatives
for which hypnotic properties might be predicted on the basis of
their distribution coefficient arnl molecular stability are generally
inert.
H ypnone ( acetophenone) perhaps comes the nearest to being
an aromatic hypnotic, but a further increase in the aromatic groupings, as in benzophenone :i.nd benzhydrol, causes the hypnotic action to disappear. It is of interest to note that the two barbituric
acids under discussion consist essentially of two benzene rings and
one pyrimidine ring, that is, they are preponderantly aromatic.
Published by UNI ScholarWorks, 1923
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The hydantoins furnish a parallel case; phenylethylhydantoin,
mainly aliphatic, is a hypnotic, while diphenylhydantoin, mainly
aromatic, is not. Fnrther evidence is, of course, required to establish this point, but from the data at hand it would appear that a
search for hypnotics among derivatives that are essentially aromatic is not very promising.
Experimental hypnotics must, of course . be thoronghly tested
out with animals before even preliminary tests are made with human subjects. Various animals have been used for this purpose.
Fischer and ::\T ering's original experiments with veronal and its
homologs were performed with dogs. The more active hypnotics
when administered orally in a one gram dose to a dog of a\'erage
weight cause first a marked muscular incoordination followed by
drowsiness and finally sleep which lasts six or eight hours. \Ve
fournl in our experiments that preliminary tests conld be performed very satisfactorily with white mice by intraperitoneal injections of either an ac1neons solution of the sodium salt or an
olive oil solution of the free acid. The advantages of this method
are the smaller amount of material re(1uired for the test, a great
saving of laboratory space and the avoidance of certain disagreeable features always met with in experimentation with larger
animals. For example the effective dose of veronal fc;r a twenty
gram mouse is only 0.006 g. \Vithin twenty minutes the mouse
is in a state of coma which lasts for several hours, after which
recovery takes place without any apparent after-effects. This
method we have found very useful as a preliminary test to eliminate from further consideration derivatives which are physiologically inert.
From our study thus far of the barbituric acids certain negative data are presented for the purpose of narrowing clown the
scope of future investigation. The following tentative conclusions may be drawn, supplementary to those of Fischer and Mering.
1. To manifest hypnotic action without undesirable after-effects, the two alkyl groups in the 5-position of the pyrimidine
ring should have a total number of carbon atoms not less than
four or more than eight.
2. At least one of the alkyl groups must be in the form of an
open chain.
3. The benzyl group is undesirable because of its tendency to
cause convulsions.
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4. The urea grouping -NH-CO-NH- may not be replaced by
the amidine grnupiug -NH-CR=.:\-.
5. Increase in the size of the molernle heyoncl, say, a molecular weight of 250 results in loss of hypnotic activity.
6. · Not more than one of the two alkyl groups should be aromatic in character.
7. \Ve believe that the hypnophore group in the veronal series
is -CR,-CO-N H-CO-.
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